Table 4.
Sequelae of external‐beam radiation therapy (EBRT) according to RTOG criteria
| n | RTOG grade, n (%) | ||||
|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | ||
| GI | |||||
| Anorexia | 136 | 37 (27.2%) | 10 (7.4%) | 3 (2.2%) | 0 |
| Nausea/vomiting | 136 | 16 (11.8%) | 4 (2.9%) | 2 (1.5%) | 0 |
| Diarrhea | 136 | 2 (1.5%) | 1 (0.7%) | 0 | 0 |
| Gastroduodenal ulcer | 136 | – | 10 (7.4%) | 1 (0.7%) | 0 |
| Liver | |||||
| Total bilirubin | 136 | 15 (11%) | 12 (8.8%) | 0 | 0 |
| ALT | 136 | 26 (19.1%) | 1 (0.7%) | 5 (3.7%) | 0 |
| AST | 136 | 35 (25.7%) | 15 (11%) | 6 (4.4%) | 0 |
| ALP | 136 | 47 (34.6%) | 8 (5.9%) | 1 (0.7%) | 0 |
| Marrow | |||||
| Hb | 136 | 58 (42.6%) | 21 (15.4%) | 0 | 0 |
| WBC | 136 | 35 (25.7%) | 28 (20.6%) | 7 (5.1%) | 1 (0.7%) |
| Platelets | 136 | 22 (16.2%) | 33 (24.3%) | 34 (25%) | 0 |
ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GI, gastrointestinal; Hb, hemoglobin; RTOG, Radiation Therapy Oncology Group; WBC, white blood cells.